Community Healthcare Trust announced a dividend reduction that shifts $25 to $30 million in annual retained capital toward property acquisitions. The cut moves the monthly distribution from $0.4425 to $0.3775 per share, a 14.7% reduction effective immediately. Management cited cap rate compression in medical office buildings and the need for dry powder in a market where smaller healthcare facilities trade at wide bid-ask spreads.
The REIT owns 201 properties across 34 states, concentrated in outpatient clinics, physician offices, and surgery centers leased to regional health systems. Average lease term sits at 8.2 years with 2.1% annual escalators. Occupancy runs at 94.6%, in line with the sector but below the 96-97% range of larger peers. The retained capital represents roughly 9% of CHCT's $280 million market capitalization, meaningful firepower for a portfolio that added only $41 million in acquisitions over the prior twelve months.
The redeployment matters because healthcare real estate bifurcated after the regional banking crisis. Institutional buyers—Welltower, Healthpeak, Ventas—chase $50 million-plus trophy assets in MSAs with teaching hospitals. Community Healthcare operates in the $3 to $8 million per-property range, competing against local buyers who lost financing access when banks tightened. Properties in tertiary markets now clear at 8.5 to 9.2% cap rates, 150 to 200 basis points wider than eighteen months ago. A REIT with balance-sheet capacity and a 6.1x debt-to-EBITDA ratio can acquire at yields that immediately exceed its 6.8% cost of equity.
The dividend cut also removes pressure from a distribution that consumed 92% of funds from operations in the most recent quarter. Payout ratios above 85% create refinancing risk when debt matures—CHCT has $95 million rolling in 2026 and $110 million in 2027. Retained cash lets management either pay down revolver draws or pre-fund acquisitions without tapping the unsecured bond market, where BBB-minus credits currently price at SOFR plus 210.
Operators should track two data points over the next six months. First, whether CHCT deploys the retained capital into acquisitions at cap rates above 8.75%, the threshold where accretion justifies the dividend sacrifice. Second, whether occupancy holds above 94% as three physician group leases—totaling 38,000 square feet—expire in Q2 and Q3 2025. If renewals reprice lower or go dark, the acquisition story weakens. Management guided to $35 to $45 million in 2025 acquisitions during the last earnings call; the retained $25-30 million suggests they expect to fund the balance through asset sales or revolver capacity.
The stock trades at $26.40, a 5.7% distribution yield post-cut and 0.94x price-to-book. The discount to NAV reflects skepticism that a subscale REIT can compete for quality assets without overpaying, and concern that tenant credit deteriorates faster than lease escalators can offset. The next acquisition announcement—expected within 90 days based on pipeline commentary—will clarify whether the capital redeployment funds growth or merely props up a portfolio losing relevance in a consolidating sector.